Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05042765 · ClinicalTrials.gov registry record
Entheogen Resurgence
A clinical trial, sponsored by Vireo Health.
- Completed
- Registry status
- 102
- Enrollment target
NCT05042765 is a clinical trial that has completed, run by Vireo Health. The registered enrollment target is 102 participants.
The verdict
NCT05042765 has completed, sponsored by Vireo Health.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
For the purpose of this anonymous, observational pilot survey, the investigators will define "entheogens" as substances, generally derived from plants, that are ingested in order to impact one's consciousness for therapeutic, religious, or spiritual purposes. This survey will focus on the naturalistic use of entheogens and other substances including kambo, ayahuasca, hapé, bufo, and sananga typically used in specific cultural and spiritual contexts for healing. There are substantial limitations to what the healthcare community knows about the intentions, motivations, experiences, health behaviors, and demographics of people who decide to participate in entheogen therapy centers or retreats and their willingness to participate in future research studies. The primary goal of this observational pilot survey is to collect self-reported, anonymous data from people who have opted to participate in entheogen therapy centers and retreats during the last five (5) years on the topics of their initial intentions, motivations, experiences, demographics, and willingness to participate in future entheogen research. With the support of established therapy and retreat centers, the research team will aim to collect 100 survey responses from unique, unidentified individuals who have participated in some form of entheogen therapy or treatment during the last five (5) years. Those who choose to fill out the survey will be at least 18 years of age, fluent in English, and self-reporting participation in therapy or a retreat which utilized entheogens in a naturalistic setting in the past five (5) years.
Interventions
- OTHER self-reported entheogen use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2021-09-16 |
| Est. Completion | 2022-01-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05042765
The ClinicalTrials.gov registry entry for NCT05042765 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vireo Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which self-reported entheogen use is the first listed.
NCT05042765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05042765 about?
NCT05042765 is a clinical study titled "Entheogen Resurgence". For the purpose of this anonymous, observational pilot survey, the investigators will define "entheogens" as substances, generally derived from plants, that are ingested in order to impact one's consciousness for therapeutic, religious, or spiritual purposes. This survey will focus on the naturalist...
What is the current status of trial NCT05042765?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2021-09-16. Estimated completion is 2022-01-12.
What interventions are being tested in trial NCT05042765?
The interventions under investigation include: self-reported entheogen use (OTHER).
Who is sponsoring clinical trial NCT05042765?
This trial is sponsored by Vireo Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.